PT  - JOURNAL ARTICLE
AU  - Hambley, H
AU  - Davidson, J F
AU  - Walker, I D
AU  - Small, M
AU  - Prentice, C R
TI  - Freeze dried cryoprecipitate: a clinical evaluation.
AID  - 10.1136/jcp.36.5.574
DP  - 1983 May 01
TA  - Journal of Clinical Pathology
PG  - 574--576
VI  - 36
IP  - 5
4099  - http://jcp.bmj.com/content/36/5/574.short
4100  - http://jcp.bmj.com/content/36/5/574.full
SO  - J Clin Pathol1983 May 01; 36
AB  - Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.